MXPA02008110A - Liposomas terapeuticos radioactivos. - Google Patents

Liposomas terapeuticos radioactivos.

Info

Publication number
MXPA02008110A
MXPA02008110A MXPA02008110A MXPA02008110A MXPA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A
Authority
MX
Mexico
Prior art keywords
liposomes
radioactive therapeutic
therapeutic liposomes
radioactive
ionophores
Prior art date
Application number
MXPA02008110A
Other languages
English (en)
Inventor
Roy H Larsen
Original Assignee
Anticancer Therapeutic Inv Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anticancer Therapeutic Inv Sa filed Critical Anticancer Therapeutic Inv Sa
Publication of MXPA02008110A publication Critical patent/MXPA02008110A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1072—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MXPA02008110A 2000-02-21 2001-02-21 Liposomas terapeuticos radioactivos. MXPA02008110A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20000855A NO312708B1 (no) 2000-02-21 2000-02-21 Radioaktive liposomer til terapi
PCT/NO2001/000065 WO2001060417A2 (en) 2000-02-21 2001-02-21 Radioactive therapeutic liposomes

Publications (1)

Publication Number Publication Date
MXPA02008110A true MXPA02008110A (es) 2003-12-11

Family

ID=19910768

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02008110A MXPA02008110A (es) 2000-02-21 2001-02-21 Liposomas terapeuticos radioactivos.

Country Status (21)

Country Link
US (1) US6592843B2 (es)
EP (1) EP1257299B9 (es)
JP (1) JP4933712B2 (es)
KR (1) KR100822566B1 (es)
CN (1) CN100350981C (es)
AT (1) ATE300316T1 (es)
AU (2) AU3782701A (es)
BR (1) BR0108572A (es)
CA (1) CA2400994C (es)
CZ (1) CZ299032B6 (es)
DE (1) DE60112251T2 (es)
DK (1) DK1257299T3 (es)
EA (1) EA005624B1 (es)
ES (1) ES2247069T3 (es)
MX (1) MXPA02008110A (es)
NO (1) NO312708B1 (es)
NZ (1) NZ520848A (es)
PL (1) PL201398B1 (es)
UA (1) UA73160C2 (es)
WO (1) WO2001060417A2 (es)
ZA (1) ZA200206500B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO310544B1 (no) * 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
NO314537B1 (no) * 1999-12-06 2003-04-07 Anticancer Therapeutic Inv Sa Reseptorbindende konjugater
US8029795B2 (en) * 1999-12-30 2011-10-04 Gwathmey, Inc. Targeted iron chelator delivery system
WO2001097859A1 (en) * 2000-06-16 2001-12-27 Sloan-Kettering Institute For Cancer Research Liposomal encapsulation of chelated actinium-225 and uses thereof
US20040166060A1 (en) * 2000-06-16 2004-08-26 Sloan Kettering Institute For Cancer Research Liposomal encapsulation of alpha particle emittors and uses thereof
NO313180B1 (no) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
US6869591B2 (en) * 2002-03-26 2005-03-22 Barnes-Jewish Hospital Paramagnetic particles that provide improved relaxivity
GB0213261D0 (en) * 2002-06-10 2002-07-17 Anticancer Therapeutic Inv Sa Method
NZ543044A (en) * 2003-04-15 2010-04-30 Algeta As Thorium-227 for use in radiotherapy of soft tissue disease
GB0308731D0 (en) * 2003-04-15 2003-05-21 Anticancer Therapeutic Inv Sa Method of radiotherapy
JP2007505043A (ja) * 2003-09-09 2007-03-08 ギリアード サイエンシーズ， インコーポレイテッド 処置用リポソーム
EA020542B1 (ru) * 2004-02-20 2014-12-30 Алгета Ас Альфа-излучающие частицы гидроксиапатита
US20070053845A1 (en) * 2004-03-02 2007-03-08 Shiladitya Sengupta Nanocell drug delivery system
AU2005219413A1 (en) * 2004-03-02 2005-09-15 Massachusetts Institute Of Technology Nanocell drug delivery system
GB0423565D0 (en) * 2004-10-22 2004-11-24 Algeta As Formulation
WO2006099445A2 (en) * 2005-03-14 2006-09-21 Massachusetts Institute Of Technology Nanocells for diagnosis and treatment of diseases and disorders
US8709380B1 (en) * 2006-02-07 2014-04-29 Sirius Medicine, Llc Targeting agents for enhancing radiation therapy
US20070224115A1 (en) * 2006-03-22 2007-09-27 The Regents Of The University Of California Polymeric chelators for radionuclide delivery systems
CN101485629B (zh) * 2008-01-16 2013-01-23 沈阳药科大学 一种给药系统及其制备方法
US20100178244A1 (en) * 2009-01-13 2010-07-15 Arnsdorf Morton F Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
US20100178245A1 (en) * 2009-01-13 2010-07-15 Arnsdorf Morton F Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions
US8920775B2 (en) 2009-07-17 2014-12-30 Technical University Of Denmark Loading technique for preparing radionuclide containing nanoparticles
JP2011111438A (ja) * 2009-11-30 2011-06-09 Akita Univ 有機金属錯体を有効成分として含有する抗がん剤
GB201002508D0 (en) 2010-02-12 2010-03-31 Algeta As Product
CA2821024A1 (en) * 2010-12-14 2012-06-21 Technical University Of Denmark Entrapment of radionuclides in nanoparticle compositions
GB201105298D0 (en) * 2011-03-29 2011-05-11 Algeta Asa Pharmaceutical preparation
DE102011079031A1 (de) * 2011-07-12 2013-01-17 Algeta Asa Flüssigkeitsbehälter
GB201208309D0 (en) 2012-05-11 2012-06-27 Algeta As Complexes
WO2014164712A1 (en) 2013-03-11 2014-10-09 Wayne State University Formation and uses of europium
US9433690B1 (en) * 2015-02-26 2016-09-06 Sciencons AS Radiopharmaceutical solutions with advantageous properties
KR102630614B1 (ko) * 2015-02-26 2024-01-26 사이언콘스 에이에스 이로운 특성을 갖는 방사성약물 용액들
EP3061464B1 (en) * 2015-02-26 2017-10-25 Sciencons AS Radiopharmaceutical solutions with advantageous properties
RS56646B1 (sr) * 2015-07-03 2018-03-30 Oncoinvent As Radioterapijske čestice i suspenzije
WO2017162555A1 (en) 2016-03-24 2017-09-28 Bayer Pharma Aktiengesellschaft Radio-pharmaceutical complexes
BR112018075554A2 (pt) 2016-06-10 2019-10-01 Bayer Pharma Aktiengesellschaft complexos radiofarmacêuticos
JP7176958B2 (ja) * 2016-06-24 2022-11-22 サイエンコンス アクスイェ セルスカプ ２１２Ｐｂ標識モノクローナル抗体の調製
CA3059534A1 (en) 2017-05-11 2018-11-15 Alpha Tau Medical Ltd. Polymer coatings for brachytherapy devices
JP7675422B2 (ja) 2018-04-02 2025-05-13 アルファ タウ メディカル リミテッド 放射性核種の管理された放出
CA3148382A1 (en) 2019-07-25 2021-01-28 Bayer As Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer
IL293575A (en) 2019-12-05 2022-08-01 Sciencons AS Production of 212 lead in a high degree of purity
IL303002A (en) 2020-12-16 2023-07-01 Alpha Tau Medical Ltd Radiotherapy by diffuse alpha emitters with increased beta therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310506A (en) * 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
DK482685D0 (da) * 1984-10-22 1985-10-21 Hope Nat Medical Center Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme
ATE88642T1 (de) 1987-11-04 1993-05-15 Vestar Inc Zusammensetzung und verfahren zur anwendung von in liposomen eingeschlossenen verbindungen in der neutroneneinfangtherapie von tumoren.
US5527528A (en) * 1989-10-20 1996-06-18 Sequus Pharmaceuticals, Inc. Solid-tumor treatment method
EP1138334A3 (en) * 1992-06-09 2002-04-03 Neorx Corporation Pretargeting methods and compounds
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
ES2299256T3 (es) * 1998-05-26 2008-05-16 Sloan-Kettering Institute For Cancer Research Constructos que emiten particulas alfa y sus usos.

Also Published As

Publication number Publication date
PL201398B1 (pl) 2009-04-30
WO2001060417A3 (en) 2002-02-07
KR100822566B1 (ko) 2008-04-16
EP1257299B9 (en) 2005-11-30
ATE300316T1 (de) 2005-08-15
EA200200793A1 (ru) 2003-02-27
KR20020092963A (ko) 2002-12-12
UA73160C2 (uk) 2005-06-15
CA2400994C (en) 2009-07-07
ES2247069T3 (es) 2006-03-01
AU3782701A (en) 2001-08-27
WO2001060417A2 (en) 2001-08-23
NO20000855D0 (no) 2000-02-21
CZ20023164A3 (cs) 2003-04-16
NO312708B1 (no) 2002-06-24
EA005624B1 (ru) 2005-04-28
AU2001237827B8 (en) 2001-08-27
NO20000855L (no) 2001-08-22
US6592843B2 (en) 2003-07-15
BR0108572A (pt) 2002-11-19
DK1257299T3 (da) 2005-11-21
DE60112251T2 (de) 2006-03-30
NZ520848A (en) 2005-02-25
EP1257299A2 (en) 2002-11-20
CN100350981C (zh) 2007-11-28
PL358541A1 (en) 2004-08-09
AU2001237827B2 (en) 2007-11-22
CA2400994A1 (en) 2001-08-23
DE60112251D1 (de) 2005-09-01
US20010048914A1 (en) 2001-12-06
CZ299032B6 (cs) 2008-04-09
JP2003522808A (ja) 2003-07-29
ZA200206500B (en) 2003-08-14
EP1257299B1 (en) 2005-07-27
CN1404402A (zh) 2003-03-19
JP4933712B2 (ja) 2012-05-16

Similar Documents

Publication Publication Date Title
AU3782701A (en) Radioactive therapeutic liposomes
GB0105772D0 (en) Use
AU5984701A (en) Method of treating immune pathologies with low dose estrogen
MXPA04009163A (es) Nuevos compuestos.
EP1242106A4 (en) IMPROVING INHALATION THERAPY USING CARBON GAS
MY153151A (en) Inhalation kit comprising inhalable powder of tiotropium
BR0114316A (pt) Processo para a preparação de formulações em pó
NZ522368A (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
EP0249735A3 (en) Pharmaceutical preparations comprising as active agent 2-phenyl-1.2-benzisoselenazol-3(2h)-one, for the treatment of diseases caused by oxidative stress
DE59800935D1 (en) Immuntolerante prothrombinkomplex-präparation
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
TR200200263T2 (tr) Yeni seçiçi retinoid agonistleri
AU7090601A (en) Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid
BR0016864A (pt) Sistema de fornecimento de quelante de ferro, e, métodos de preparação de um sistema de fornecimento de quelante de ferro e de tratamento de sobrecarga de ferro em um mamìfero em necessidade de tratamento
MY121523A (en) Resorcinol derivatives
IL150367A0 (en) Method for the preparation of citalopram
MY137580A (en) Radioactive therapeutic liposomes
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
ZA200303045B (en) Inhalable formulation of a solution containing a tiotropium salt.
GB9929485D0 (en) Tramadol salts thereof and process for their preparation
AP1413A (en) Rescorcinol composition.
YU112585A (en) Process for obtaining l-norcarnitine hydro-chloride
UA30267A (uk) Протирикетсійний фітозасіб
UA30266A (uk) Протихламідійний фітозасіб
IT1313683B1 (it) Procedimento per la preparazione di marbofloxacina.

Legal Events

Date Code Title Description
FG Grant or registration